RXO (NYSE:RXO) Sets New 1-Year High – Still a Buy?

Rxo Inc (NYSE:RXOGet Free Report)’s stock price reached a new 52-week high on Tuesday . The stock traded as high as $29.90 and last traded at $29.2290, with a volume of 71245 shares traded. The stock had previously closed at $28.87.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Wells Fargo & Company raised their price target on shares of RXO from $15.00 to $22.00 and gave the stock an “equal weight” rating in a report on Friday, May 8th. UBS Group boosted their price objective on shares of RXO from $22.00 to $26.00 and gave the company a “neutral” rating in a report on Tuesday, June 30th. Morgan Stanley reissued an “equal weight” rating and issued a $22.00 target price (up from $19.00) on shares of RXO in a research report on Thursday, May 7th. The Goldman Sachs Group raised their target price on RXO from $18.00 to $20.00 and gave the stock a “neutral” rating in a research note on Thursday, July 16th. Finally, Wall Street Zen upgraded RXO from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Four analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, RXO has an average rating of “Hold” and a consensus price target of $23.57.

Read Our Latest Analysis on RXO

RXO Price Performance

The firm’s fifty day moving average price is $25.85 and its 200 day moving average price is $19.23. The firm has a market capitalization of $4.79 billion, a PE ratio of -47.64 and a beta of 2.03. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.28.

RXO (NYSE:RXOGet Free Report) last issued its earnings results on Thursday, May 7th. The company reported ($0.09) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.09). The firm had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.34 billion. RXO had a negative net margin of 1.83% and a negative return on equity of 1.16%. The firm’s revenue was down .6% compared to the same quarter last year. During the same quarter last year, the company posted ($0.03) earnings per share. As a group, equities analysts forecast that Rxo Inc will post 0.07 earnings per share for the current year.

Institutional Investors Weigh In On RXO

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Flagship Harbor Advisors LLC purchased a new position in shares of RXO during the 4th quarter valued at about $25,000. Cassaday & Co Wealth Management LLC purchased a new stake in shares of RXO in the first quarter worth about $29,000. Geneos Wealth Management Inc. purchased a new stake in shares of RXO in the first quarter worth about $30,000. Quarry LP acquired a new stake in RXO during the third quarter worth about $33,000. Finally, City Holding Co. grew its holdings in RXO by 227.6% during the second quarter. City Holding Co. now owns 1,245 shares of the company’s stock worth $34,000 after acquiring an additional 865 shares during the period. 92.73% of the stock is owned by institutional investors and hedge funds.

RXO Company Profile

(Get Free Report)

RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.

Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.

See Also

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.